Abstract
There is high morbidity associated with local recurrence of rectal cancer. However, the adjuvant therapies given to prevent such recurrences also have significant side effects and associated risks. The ability to select patients with the highest risk of recurrence and greatest therapeutic response will improve rectal cancer care. © 2009 American Association for Cancer Research.
Cite
CITATION STYLE
APA
Myers, A. P., Meyerhardt, J. A., & Cantley, L. C. (2009, November 15). Getting knit-PI3Ky: PIK3CA mutation status to direct multimodality therapy? Clinical Cancer Research. https://doi.org/10.1158/1078-0432.CCR-09-2305
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free